{
  "id": 5388,
  "url": "https://nnemf.org/research/5388-electromagnetic-field-induced-stimulation-of-bruton-s-tyrosine",
  "title": "Electromagnetic field-induced stimulation of Bruton's tyrosine kinase.",
  "authors": [
    "D Kristupaitis",
    "I Dibirdik",
    "A Vassilev",
    "S Mahajan",
    "T Kurosaki",
    "A Chu",
    "L Tuel-Ahlgren",
    "D Tuong",
    "D Pond",
    "R Luben",
    "F M Uckun"
  ],
  "journal": "The Journal of biological chemistry",
  "year": "1998",
  "doi": "10.1074/jbc.273.20.12397",
  "pmid": "9575194",
  "abstract": "Here we present evidence that exposure of DT40 lymphoma B-cells to low energy electromagnetic fields (EMF) results in activation of phospholipase C-gamma 2 (PLC-gamma2), leading to increased inositol phospholipid turnover. PLC-gamma2 activation in EMF-stimulated cells is mediated by stimulation of the Bruton's tyrosine kinase (BTK), a member of the Src-related TEC family of protein tyrosine kinases, which acts downstream of LYN kinase and upstream of PLC-gamma2. B-cells rendered BTK-deficient by targeted disruption of the btk gene did not show enhanced PLC-gamma2 activation in response to EMF exposure. Introduction of the wild-type (but not a kinase domain mutant) human btk gene into BTK-deficient B-cells restored their EMF responsiveness. Thus, BTK exerts a pivotal and mandatory function in initiation of EMF-induced signaling cascades in B-cells.",
  "effect": "mixed",
  "evidence": "low",
  "extraction": {
    "studyType": "in_vitro",
    "studyTypeLabel": "In vitro study",
    "effectDirection": "mixed",
    "evidenceLabel": "Low",
    "population": "DT40 lymphoma B-cells (chicken B-cell line)",
    "sampleSize": "—",
    "exposure": "",
    "confidencePct": "74",
    "peerReviewed": "yes",
    "mainFindings": "Exposure of DT40 lymphoma B-cells to low energy electromagnetic fields was associated with activation of PLC-gamma2 and increased inositol phospholipid turnover. EMF-induced PLC-gamma2 activation depended on BTK: BTK-deficient cells did not show enhanced PLC-gamma2 activation with EMF exposure, and reintroduction of wild-type (but not kinase-domain mutant) human btk restored EMF responsiveness.",
    "outcomes": [
      "Bruton's tyrosine kinase (BTK) stimulation/requirement",
      "Phospholipase C-gamma2 (PLC-gamma2) activation",
      "Inositol phospholipid turnover"
    ],
    "limitations": [
      "No EMF exposure parameters reported in the abstract (e.g.",
      "frequency",
      "field strength",
      "duration",
      "SAR).",
      "In vitro cell-line model",
      "generalizability to in vivo health outcomes is not addressed in the abstract.",
      "Sample size and statistical details are not provided in the abstract."
    ],
    "keywords": [
      "electromagnetic fields",
      "EMF",
      "DT40",
      "B-cells",
      "lymphoma",
      "Bruton's tyrosine kinase",
      "BTK",
      "LYN kinase",
      "TEC family",
      "protein tyrosine kinase",
      "phospholipase C-gamma2",
      "PLC-gamma2",
      "inositol phospholipid turnover",
      "signal transduction"
    ],
    "hubs": [],
    "raw": "{\n  \"study_type\": \"in_vitro\",\n  \"exposure\": {\n    \"band\": null,\n    \"source\": null,\n    \"frequency_mhz\": null,\n    \"sar_wkg\": null,\n    \"duration\": null\n  },\n  \"population\": \"DT40 lymphoma B-cells (chicken B-cell line)\",\n  \"sample_size\": null,\n  \"outcomes\": [\n    \"Bruton's tyrosine kinase (BTK) stimulation/requirement\",\n    \"Phospholipase C-gamma2 (PLC-gamma2) activation\",\n    \"Inositol phospholipid turnover\"\n  ],\n  \"main_findings\": \"Exposure of DT40 lymphoma B-cells to low energy electromagnetic fields was associated with activation of PLC-gamma2 and increased inositol phospholipid turnover. EMF-induced PLC-gamma2 activation depended on BTK: BTK-deficient cells did not show enhanced PLC-gamma2 activation with EMF exposure, and reintroduction of wild-type (but not kinase-domain mutant) human btk restored EMF responsiveness.\",\n  \"effect_direction\": \"mixed\",\n  \"limitations\": [\n    \"No EMF exposure parameters reported in the abstract (e.g., frequency, field strength, duration, SAR).\",\n    \"In vitro cell-line model; generalizability to in vivo health outcomes is not addressed in the abstract.\",\n    \"Sample size and statistical details are not provided in the abstract.\"\n  ],\n  \"evidence_strength\": \"low\",\n  \"confidence\": 0.74,\n  \"peer_reviewed_likely\": \"yes\",\n  \"keywords\": [\n    \"electromagnetic fields\",\n    \"EMF\",\n    \"DT40\",\n    \"B-cells\",\n    \"lymphoma\",\n    \"Bruton's tyrosine kinase\",\n    \"BTK\",\n    \"LYN kinase\",\n    \"TEC family\",\n    \"protein tyrosine kinase\",\n    \"phospholipase C-gamma2\",\n    \"PLC-gamma2\",\n    \"inositol phospholipid turnover\",\n    \"signal transduction\"\n  ],\n  \"suggested_hubs\": []\n}"
  },
  "synthesis": null,
  "synthesisStatus": "pending",
  "originalHref": "https://pubmed.ncbi.nlm.nih.gov/9575194/",
  "sourceUrl": "https://rfsafe.org/mel/paper.php?id=5388",
  "updated": "2026-02-14 08:19:55"
}